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ABSTRACT 21 
The involvement of Rho-associated kinase (ROK) in activation of rabbit urethral smooth muscle 22 
contraction was investigated by examining the effects of two structurally distinct inhibitors of ROK, 23 
Y27632 and H1152, on the contractile response to electric field stimulation (EFS), membrane 24 
depolarization with KCl, and α1-adrenoceptor stimulation with phenylephrine. Both compounds 25 
inhibited contractions elicited by all three stimuli. The protein kinase C inhibitor, GF109203X, on the 26 
other hand, had no effect. Urethral smooth muscle strips were analysed for phosphorylation of three 27 
potential direct or indirect substrates of ROK: (i) myosin regulatory light chains (LC20) at S19; (ii) the 28 
myosin targeting subunit of myosin light chain phosphatase, MYPT1, at T697 and T855; and (iii) cofilin 29 
at S3. The following results were obtained: (i) under resting tension, LC20 was phosphorylated to 0.65 30 
± 0.02 mol Pi/mol LC20 (n = 21) at S19; (ii) LC20 phosphorylation did not change in response to KCl or 31 
phenylephrine; (iii) ROK inhibition had no effect on LC20 phosphorylation in the absence or presence of 32 
contractile stimuli; (iv) under resting conditions, MYPT1 was partially phosphorylated at T697 and 33 
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T855 and cofilin at S3; (v) phosphorylation of MYPT1 and cofilin was unaffected by KCl or 34 
phenylephrine; and (vi) KCl- and phenylephrine-induced contraction-relaxation cycles did not correlate 35 
with actin polymerization-depolymerization. We conclude that ROK plays an important role in urethral 36 
smooth muscle contraction, but not via inhibition of MLCP or polymerization of actin.     37 
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 39
INTRODUCTION 40 
 41
Lower urinary tract function is dependent on the concerted action of the smooth and striated muscles of 42 
the urinary bladder, urethra and periurethral region. Failure to store urine can lead to various forms of 43 
incontinence, which is a major health concern (26), but current therapies for incontinence have severe 44 
limitations (19). Further therapeutic development will depend on the identification of novel targets. The 45 
bladder and urethra work as a functional unit with a reciprocal relationship under normal conditions, i.e., 46 
during the storage phase, the detrusor muscle of the bladder is relaxed while the urethra is contracted to 47 
allow gradual filling of the bladder with urine and prevent leakage. On the other hand, during voiding, 48 
the urethra relaxes and the detrusor contracts to facilitate emptying of the bladder (36). An isolated rat 49 
urethral preparation is “continent” in the absence of external neural input, but flow ensues when the 50 
smooth muscle is relaxed (29). Furthermore, stimulation of the skeletal muscle makes remarkably little 51 
difference to the ability of the contracted urethra to retain fluid. Conte et al (12) also found that 52 
paralyzing the striated muscle encircling the urethra of anesthetized rats with d-tubocurarine did not 53 
result in urine leakage. It would appear, therefore, that skeletal muscle is more important for resisting 54 
rapid pressure rises caused by coughing or laughing, for example, than for maintaining a constant 55 
urethral tone, which makes sense from an energetic standpoint. The smooth muscle cells of the urethra, 56 
therefore, play a critical role in continence by remaining in a contracted state most of the time, thereby 57 
retaining urine within the bladder. This smooth muscle tone can be modified by adrenergic and 58 
cholinergic nerve stimulation (4). Noradrenaline, released by adrenergic neurons, is the major excitatory 59 
transmitter in the rabbit urethra (3,13). At the appropriate time, the smooth muscle cells relax in 60 
response to inhibitory nerves, and detrusor smooth muscle contraction voids the bladder through a 61 
relaxed urethra. Nitric oxide, released by non-adrenergic, non-cholinergic neurons, is an important 62 
mediator of urethral smooth muscle relaxation (5,11).  63 
 Deficiencies in urethral closure can result in stress urinary incontinence. Treatment of this 64
condition, which is based mainly on α1-adrenoceptor agonists, has been disappointing (6). In order to 65 
improve strategies for treatment of incontinence, it is essential to understand urethral function and 66 
regulation in greater detail.  67 
 Smooth muscle contraction and relaxation are regulated primarily by the phosphorylation and 68
dephosphorylation of the 20-kDa regulatory light chains of myosin (LC20) (2). Smooth muscle myosin II 69 
is a hexameric protein composed of two heavy chains (205 kDa) and two pairs of light chains (17 and 20 70 
kDa). Contraction is activated by an increase in cytosolic free Ca2+ concentration ([Ca2+]i), whereupon 71 
Ca2+ binds to calmodulin (CaM) and the (Ca2+)4-CaM complex activates myosin light chain kinase 72 
(MLCK). Activated MLCK phosphorylates LC20 at S19, resulting in cross-bridge cycling of myosin 73 
along the actin filaments and contraction. Relaxation occurs when [Ca2+]i returns to resting levels upon 74 
removal of the contractile stimulus, whereupon LC20 is dephosphorylated by myosin light chain 75 
phosphatase (MLCP) and myosin dissociates from actin (18).  76 
 An important aspect of the regulation of smooth muscle contraction that has emerged in recent 77
years concerns the phenomenon of Ca2+ sensitization, i.e., the ability of a variety of agonists to elicit a 78 
contractile response without an increase in [Ca2+]i (33). Ca2+ sensitization involves agonist-induced 79 
activation of signaling pathways, primarily the RhoA/Rho-associated kinase (ROK) pathway, that 80 
terminate in the inhibition of MLCP. This shifts the balance between kinase and phosphatase in favor of 81 
MLCK so that a higher level of LC20 phosphorylation (and force) is achieved at a given [Ca2+]i. ROK 82 
mediates MLCP inhibition via phosphorylation of the myosin targeting subunit of the phosphatase 83 
(MYPT1) at T697 and/or T855 (rat numbering; NCBI accession number EDM16761) (16,31,39) or of 84 
the 17 kDa cytosolic protein, CPI-17, which becomes a potent inhibitor of MLCP when phosphorylated 85 
at T38 (27). 86 
 Studies regarding the role of LC20 phosphorylation in urethral contractile physiology have been 87
rather limited. Hypolite et al (21) reported that the rabbit urethra exhibits a low level of basal LC20 88 
phosphorylation (12.8%). Modest increases in LC20 phosphorylation, from 16% at rest to 28 % at half-89 
maximal bethanecol-induced force, 29% at 80% maximal force and 27% at maximal force, were 90 
measured (21). A role for RhoA and ROK in urethral tone was indicated by the demonstration that 91 
inhibition of RhoA with Clostridium difficile toxin B or of ROK with Y27632 abolished porcine urethral 92 
tone without affecting cytosolic free Ca2+ concentration (28). ROK inhibition also inhibited the 93 
contractile response of rat urethral smooth muscle to phenylephrine, endothelin-1, α,β-methylene ATP 94 
and membrane depolarization, but had no significant effect on baseline tension (37). 95 
 The overall aim of this work, therefore, was to gain further insights into the molecular 96
mechanisms involved in the regulation of  urethral smooth muscle contraction. The following specific 97 
questions were addressed: (i) Is the contraction of urethral smooth muscle in response to electric field 98 
stimulation, membrane depolarization by KCl or α1-adrenoceptor stimulation with phenylephrine 99 
attenuated by inhibition of ROK? (ii) Does the sustained contraction of urethral smooth muscle involve 100 
phosphorylation of LC20? (iii) Does contraction of urethral smooth muscle correlate with the 101 
phosphorylation of MYPT1 at T697 and/or T855? (iv) Does the contraction-relaxation cycle of urethral 102 
smooth muscle correlate with actin polymerization-depolymerization? 103 
 104
 105
MATERIALS AND METHODS 106 
 107
   Materials. Antibodies: rabbit polyclonal anti-calponin was raised in-house against purified full-length 108
chicken gizzard calponin (42). Commercial antibodies were purchased from the following sources: 109 
rabbit polyclonal anti-LC20 (Santa Cruz Biotechnology) raised against the full-length human protein; 110 
rabbit polyclonal anti-pS19-LC20 (Rockland) raised against a synthetic phosphopeptide corresponding to 111 
the region of the human protein containing pS19; rabbit polyclonal anti-CPI-17 (Upstate) raised against 112 
full-length recombinant porcine CPI-17; rabbit polyclonal anti-actin (Cytoskeleton) raised against a 113 
synthetic peptide corresponding to the C-terminal 11 residues of human actin (SGPSIVHRKCF); goat 114 
polyclonal anti-SM-22α (Novus Biologicals) raised against a synthetic peptide (MTGYGRPRQIIS) 115 
corresponding to residues 189 - 200 of human SM-22α; rabbit polyclonal anti-pT697-MYPT1 (Upstate) 116 
raised against a synthetic phosphopeptide corresponding to the region around pT697 of the human 117 
protein; rabbit polyclonal anti-pT855-MYPT1 (Upstate) raised against a synthetic phosphopeptide 118 
corresponding to the region around pT855 of the human protein; rabbit polyclonal anti-pS3-cofilin (Cell 119 
Signaling Technology) raised against a synthetic phosphopeptide corresponding to human cofilin 120 
containing phosphoserine at position 3; rabbit polyclonal anti-cofilin (Cell Signaling Technology) raised 121 
against a synthetic peptide corresponding to human cofilin containing serine at position 3. Nω-nitro-L-122 
arginine,  atropine, phenylephrine and phorbol 12,13-dibutyrate were purchased from Sigma, Y27632 123 
from BioMol International, H1152, GF109203X, wortmannin and calyculin-A from Calbiochem, and 124 
microcystin-LR from Alexis Biochemicals. Molecular weight markers were purchased from Fermenta.  125 
Isolation of urethral tissue for tension measurements. Male New Zealand white rabbits (3 - 4 kg) 126 
were maintained and killed with a lethal injection of pentobarbitone according to the standards of the 127 
Canadian Council on Animal Care and a protocol approved by the Animal Care Committee of the 128 
Faculty of Medicine, University of Calgary, and in accordance with the European Union legislation and 129 
ethical standards. Male Sprague-Dawley rats (250 - 275 g) were maintained and killed by halothane 130 
inhalation and decapitation according to the standards of the Canadian Council on Animal Care and a 131 
protocol approved by the Animal Care Committee of the Faculty of Medicine, University of Calgary. 132 
The proximal 1 cm of the urethra was removed and placed in Krebs solution (120 mM NaCl, 5.9 mM 133 
KCl, 25 mM NaHCO3, 5.5 mM glucose, 1.2 mM NaH2PO4, 1.2 mM MgCl2, 2.5 mM CaCl2) plus 100 134 
μM Nω-nitro-L-arginine and 1 μM atropine with pH adjusted to 7.4 with 95% O2/5% CO2. The 135 
muscarinic antagonist atropine was included to block the effects of acetylcholine released from nerves, 136 
and Nω-nitro-L-arginine to block nitric oxide effects. In separate experiments, we found that omission of 137 
these inhibitors had no statistically significant effect on LC20 phosphorylation levels, as determined by 138 
paired Student’s t test: 0.62 ± 0.11 mol Pi/mol LC20 in their presence and 0.52 ± 0.10 mol Pi/mol LC20 in 139 
their absence (p > 0.05, n = 3). Circularly-oriented strips (8 x 1 x 1 mm) of smooth muscle were 140 
dissected. For investigation of the effects of protein kinase inhibitors, muscle strips were placed in a 141 
water-jacketed organ bath maintained at 37 oC, and perfused with warmed Krebs solution bubbled with 142 
95% O2/5% CO2. Strips were adjusted to a tension of 0.5 g, the optimal tension for KCl-induced force 143 
development, and allowed to equilibrate for 60 min before experimentation began.  During the period of 144 
equilibration of the tissue after mounting, it was necessary to stretch the tissue periodically to maintain 145 
resting tension at 0.5 g. Stable tension was always achieved within the 60-min equilibration period. Prior 146 
experiments indicated that a resting tension of 0.5 g for tissue strips of the dimensions used in this study 147 
gave a maximal contractile response to KCl. Contractions in response to electric field stimulation (EFS), 148 
KCl and phenylephrine were measured using Statham UC3 and Dynamometer UF1 transducers, with the 149 
outputs recorded on a Grass 7400 chart recorder. Tissues did not exhibit significant loss of maximal 150 
tension in response to repetitive stimuli (EFS, KCl or phenylephrine) over several hours. Field 151 
stimulation was applied via platinum ring electrodes mounted at either end of the tissue strip. Pulses of 152 
0.3 ms duration were delivered in trains at constant frequencies of 4 Hz from a Grass S48 stimulator at a 153 
nominal voltage of 50 V. Responses were blocked with 1 µM tetrodotoxin, confirming that they were 154 
nerve mediated (38).     155 
Demembranation (skinning) of urethral smooth muscle strips. Urethral smooth muscle strips 156 
mounted on a force transducer at resting tension were incubated at 21 oC with 1% (v/v) Triton X-100 in 157 
30 mM TES, 50 mM KCl, 5 mM K2EGTA, 150 mM sucrose, 0.5 mM dithioerythritol, pH 7.4 for 2 h. In 158 
establishing the optimal conditions for Triton skinning of rabbit urethral smooth muscle strips, the 159 
Triton X-100 concentration and time of treatment were varied. The contractile response of the Triton-160 
skinned tissue to Ca2+ was comparable to that of the KCl-induced contraction of the intact tissue prior to 161 
Triton treatment when 1 % Triton X-100 was used for 2 h. Skinned tissues were then equilibrated with 162 
3.2 mM MgATP, 2 mM free MgCl2, 0.5 mM NaN3, 30 mM TES, 12 mM phosphocreatine, 15 units/ml 163 
creatine kinase, 1 μM calmodulin, pH 6.9 with ionic strength adjusted to 150 mM with potassium 164 
propionate. Desired free Ca2+ levels were obtained by mixing stock solutions containing K2EGTA and 165 
K2CaEGTA (41).  166 
   Protein extraction. For investigation of protein phosphorylation, muscle strips were immersed in 10% 167
trichloroacetic acid (TCA)/10 mM dithiothreitol (DTT) in acetone that had been pre-cooled on dry ice or 168 
wet ice, washed (3 x 1 min) with DTT/acetone, lyophilized overnight and the dried tissues cut into small 169 
pieces. SDS-PAGE sample buffer containing 0.1 M DTT (1 ml) was added. Tissue strips of comparable 170 
dimensions were extracted with identical volumes of SDS-gel sample buffer, and identical volumes of 171 
extract were loaded on gels for western blot analysis. The amount of extract loaded depended on the 172 
sensitivity of the individual antibodies utilized. The samples were heated at 95 oC for 10 min, rotated 173 
overnight in the cold room and stored at -20 oC until SDS-PAGE was performed. 174 
SDS-PAGE. SDS-PAGE was carried out in 1.5-mm thick mini-gels (12.5% acrylamide in the 175 
running gel (15% for CPI-17 analysis) with a 5% acrylamide stacking gel) at 200 V for 45 min in a Mini 176 
Protean 3 Cell (Bio-Rad). Following electrophoresis, gels were either stained with Coomassie Brilliant 177 
Blue or equilibrated at room temperature for 1 h with Transblot Buffer (25 mM Tris-HCl, pH 7.5, 192 178 
mM glycine, 20% methanol, 0.1% SDS for MYPT1; 10 mM CAPS, pH 11, 10% methanol for CPI-17; 179 
25 mM Tris-HCl, pH 7.5, 192 mM glycine, 20% methanol for the rest) prior to western blotting. 180 
   Western blotting. Proteins separated by SDS-PAGE were transblotted to nitrocellulose (0.2 µm; Bio-181
Rad) at 100 V for 1 h at 4 oC in a Mini Trans-Blot Electrophoretic Transfer Cell (Bio-Rad). After 182 
blotting, the nitrocellulose membrane was washed (3 x 5 min) in PBS (0.137 M NaCl, 2.68 mM KCl, 10 183 
mM Na2HPO4, 1.76 mM KH2PO4), incubated in 0.5% glutaraldehyde in PBS for 15 min to fix proteins 184 
on the membrane and washed (3 x 5 min) with Tris-buffered saline containing Tween 20 (TBST: 20 mM 185 
Tris-HCl, pH 7.5, 137 mM NaCl, 3 mM KCl, 0.05% Tween-20). The membrane was then blocked with 186 
5% non-fat dried milk in TBST for 1 h, and incubated overnight at 4 oC with 1% non-fat dried milk in 187 
TBST containing the appropriate primary antibody. Membranes were washed (4 x 5 min) in TBST, 188 
incubated with anti-rabbit IgG-horseradish peroxidase-conjugated secondary antibody (1:10,000 dilution 189 
in 1% dry milk in TBST; Chemicon) for 1 - 2 h and washed (4 x 5 min) with TBST and (1 x 5 min) with 190 
TBS before chemiluminescence signal detection using the Super-Signal West Femto reagent (Pierce). 191 
The emitted light was detected and quantified with a chemiluminescence imaging analyzer 192 
(LAS3000mini; Fujifilm) and images were analysed with MultiGauge v3.0 software (Fujifilm).  193 
   Phosphate affinity SDS-PAGE using acrylamide-pendant phosphate-binding tag. Unphosphorylated 194
and phosphorylated forms of LC20 were separated by Phos-tag SDS-PAGE (23,35). Muscle protein 195 
samples stored in SDS-PAGE sample buffer at -20 oC were electrophoresed at 30 mA/gel for 60 min in 196 
mini-gels in which 0.05 mM Phos-tag acrylamide (NARD Institute, Japan) and 0.1 mM MnCl2 were 197 
incorporated into the running gel. In control experiments, 1 mM EDTA replaced 0.1 mM MnCl2. After 198 
electrophoresis, gels were soaked in Transblot Buffer (25 mM Tris-HCl, pH 7.5, 192 glycine, 10% 199 
methanol) containing 2 mM EDTA for 15 min prior to equilibration in Transblot Buffer for 15 min. 200 
Proteins were transferred to PVDF (Roche) at 27 V overnight at 4 oC and fixed with 0.5% 201 
glutaraldehyde prior to blocking, etc. as for the normal western blotting procedure described above. 202 
   Actin polymerization assay. Actin polymerization was measured using the G-actin/F-actin in vivo 203
Assay Kit (Cytoskeleton). Rabbit urethral smooth muscle strips, mounted on a force transducer and 204 
equilibrated with Krebs solution at 21 oC, were treated as described in the appropriate figure legends, 205 
homogenized in F-actin stabilization buffer (1 ml) with a Tissue Tearor Model 985-370 Type 2 (Biospec 206 
Products) at 21 oC and centrifuged in a bench-top centrifuge at 2,000 rpm for 5 min. Supernatants were 207 
centrifuged at 100,000 x g for 1 h at 21 oC. The high-speed supernatant was carefully removed and 50 μl 208 
of 5X SDS-gel sample buffer added. The high-speed pellet was re-suspended in 250 μl of 1x SDS-gel 209 
sample buffer. Samples were heated at 95 oC for 5 min and stored at -20 oC prior to SDS-PAGE and 210 
western blotting.   211 
   Statistical analysis. Statistical analyses were performed with SigmaPlot and Prism. Results are 212
expressed as the means ± S.E.M. Values of n indicate the numbers of animals used; several tissue strips 213 
were used from each animal. Statistically significant differences were identified by Student’s t test or 214 
one-way ANOVA with Dunnett’s post-hoc test as indicated. 215 
 216
RESULTS 217 
   Effects of ROK inhibition on urethral smooth muscle contraction. The effects of ROK inhibition on the 218
contractile response of rabbit urethral smooth muscle to EFS, membrane depolarization with KCl, and 219 
α1-adrenoceptor stimulation by phenylephrine were investigated at 37 oC. Following dissection, 220 
mounting and equilibration of the tissue, several control contraction-relaxation cycles were recorded. 221 
The tissue was then incubated with ROK inhibitor (Y27632 or H1152) for 15 min prior to two additional 222 
contraction-relaxation cycles in the continued presence of inhibitor. The ROK inhibitor was then washed 223 
out and two control contraction-relaxation cycles recorded again. Representative data showing the 224 
effects of H1152 on these contractile responses are shown in Fig. 1A with cumulative quantitative data 225 
for both inhibitors in Fig. 1B. The contractile responses to EFS, KCl or phenylephrine were all markedly 226 
inhibited by both ROK inhibitors (Fig. 1A,B). Furthermore, inhibition of ROK during steady-state force 227 
maintenance in the presence of phenylephrine elicited relaxation (Fig. 1C). The general protein kinase C 228 
(PKC) inhibitor, GF109203X, on the other hand, had no significant effect on the contractile response of 229 
the urethra to any of the stimuli (Supplementary Fig. 1). The efficacy of the PKC inhibitor was verified 230 
by its ability to block the contractile response of the rabbit urethra to 0.5 μM phorbol 12,13-dibutyrate 231 
(PdBu): steady-state force in response to 0.5 µM PdBu (0.47 ± 0.13 g) was reduced to 0.20 ± 0.09 g (n = 232 
6; p < 0.01) following pre-incubation with 2 µM GF109203X. It is noteworthy that the contractile 233 
response to PdBu was very slow and reached a steady-state level of force that was much less than that 234 
induced by KCl or phenylephrine.   235 
 In order to pursue the mechanism underlying the contractile responses and the effects of ROK 236
inhibition shown in Fig. 1, it was necessary to use an experimental system that is amenable to rapid 237 
quenching for biochemical analysis. For this purpose, urethral muscle strips were mounted in a 1-ml 238 
cuvette at room temperature and the effects of ROK inhibition on phenylephrine- and KCl-induced 239 
contraction examined. Fig. 2A shows the inhibition of phenylephrine-induced contraction by H1152 (1 240 
µM): the mean maximal tension in response to phenylephrine in the presence of H1152 was 56.8% of 241 
control, compared to 118% of control following washout of the ROK inhibitor. The concentration 242 
dependence of H1152-induced relaxation of tissue pre-contracted with phenylephrine is shown in Fig. 243 
2B. Additional experiments in which longer time intervals were used between successive additions of 244 
H1152 indicated that the concentration required for half-maximal relaxation was 0.3 μM H1152 (Fig. 245 
2C). H1152 had a similar inhibitory effect on KCl-induced contraction under these conditions (data not 246 
shown).  247 
 These results indicate that contraction of rabbit urethral smooth muscle evoked by EFS, 248
membrane depolarization or α1-adrenoceptor activation involves activation of ROK, but not PKC, and 249 
suggest that contraction of the urethra may involve a significant Ca2+ sensitization. Activation of ROK 250 
has been implicated in the inhibition of MLCP through the phosphorylation of MYPT1 at T697 and/or 251 
T855 (16,31,39). ROK is also known to phosphorylate CPI-17 at T38, which converts it into a potent 252 
inhibitor of MLCP (27). Inhibition of MLCP activity would shift the kinase-phosphatase activity balance 253 
in favour of MLCK and therefore increase LC20 phosphorylation and force.  254 
   LC20 phosphorylation. To initiate the investigation of the mechanism whereby ROK regulates urethral 255
smooth muscle contraction, we measured LC20 phosphorylation levels in extracts of tissues quenched at 256 
rest and at the peak of contraction induced by phenylephrine or KCl. Phosphorylated and 257 
unphosphorylated LC20 were separated by Phos-tag SDS-PAGE and detected by western blotting with 258 
an antibody that recognizes both forms of the light chain (Fig. 3A): LC20 was phosphorylated to ~0.6 259 
mol Pi/mol LC20 at resting tension (lanes 5 and 6). Western blotting with a phosphospecific antibody that 260 
recognizes only LC20 phosphorylated at S19, the MLCK site (Fig. 3B), and Phos-tag SDS-PAGE in the 261 
presence of EDTA to chelate Mn2+ ions (Fig. 3C), confirmed the identities of the bands as labelled. 262 
Thus, only the slower migrating band was recognized by the phosphospecific antibody (Fig. 3B) and, 263 
when Mn2+ ions were chelated with EDTA, LC20 migrated as a single band with the mobility of 264 
unphosphorylated LC20 observed in the presence of Mn2+ (Fig. 3C).  Surprisingly, treatment with 265 
phenylephrine (Fig. 3A, lanes 1 and 2) or KCl (Fig. 3A, lanes 8 and 9) did not increase the level of LC20 266 
phosphorylation. The cumulative quantitative data in Table 1 confirm this conclusion. Also shown in 267 
Fig. 3A (lanes 3 and 4) is LC20 mono- and diphosphorylation (S19 and T18) in rabbit urethral smooth 268 
muscle strips contracted in response to the phosphatase inhibitor, calyculin-A. No LC20 269 
diphosphorylation was detected in response to phenylephrine or KCl (Fig. 3B). Pre-incubation with 270 
H1152 had no effect on LC20 phosphorylation in the presence of KCl or phenylephrine (Fig. 3D and 271 
Table 1).            272 
 The possibility arose that because LC20 phosphorylation was quantified after steady-state force 273
was achieved, a transient increase in LC20 phosphorylation correlating with force development may have 274 
been missed. Therefore, the time courses of LC20 phosphorylation in response to treatment with KCl and 275 
phenylephrine were investigated. Fig. 4 shows that there was, in fact, no change in LC20 phosphorylation 276 
throughout the time course of KCl- or phenylephrine-induced contraction.  277 
   MYPT1 phosphorylation. Since MYPT1 is a well known substrate of ROK in various smooth muscles, 278
we examined the phosphorylation of MYPT1 at the two ROK sites by western blotting with 279 
phosphospecific antibodies. Both sites were phosphorylated at resting tension and neither KCl nor 280 
phenylephrine changed the level of phosphorylation at either site at the peak of the contractile response 281 
(Fig. 5 and Table 2). Analysis of the time course of phosphorylation revealed that MYPT1 282 
phosphorylation at T697 and T855 did not change during the contraction elicited by either KCl (Fig. 6A 283 
and C) or phenylephrine (Fig. 6B and C). In order to determine whether T697 and T855 were 284 
stoichiometrically or only partially phosphorylated, MYPT1 phosphorylation in intact rabbit urethral 285 
strips treated with KCl was compared with Triton-skinned tissues treated with the phosphatase inhibitor 286 
microcystin. Resting levels of MYPT1 phosphorylation at T697 and T855 were unaffected by KCl 287 
treatment of intact tissues, whereas substantial increases in phosphorylation at both sites occurred upon 288 
treatment of the demembranated tissue with microcystin (Fig. 7). Densitometric analysis of the western 289 
blots gave a ratio of KCl:control signals (normalized to calponin) of 1.03 ± 0.13 and 0.79 ± 0.21 (mean 290 
± SEM, n = 3) for T697 and T855, respectively, and a ratio of microcystin:control of 2.03 ± 0.08 and 291 
8.78 ± 1.00 (mean ± SEM, n = 3) for T697 and T855, respectively. 292 
   CPI-17. Although CPI-17 is well established as a PKC substrate (24,27), it has also been implicated as 293
a ROK substrate, at least in vitro (15,25). Phosphorylation by both kinases occurs at T38 and renders 294 
CPI-17 a potent MLCP inhibitor. Therefore, we investigated the expression of CPI-17 in the rabbit 295 
urethra. Consistent with previous findings with non-vascular smooth muscles (43), the level of CPI-17 in 296 
the urethra is considerably less than in vascular smooth muscles and comparable to the level in bladder 297 
(Supplementary Fig. 2). Given the low tissue content of CPI-17, the fact that LC20 phosphorylation was 298 
unaffected by ROK inhibition (Fig. 3D and Table 1) and the lack of effect of PKC inhibition on urethral 299 
contractility (Supplementary Fig. 1), we decided not to pursue the analysis of CPI-17 phosphorylation.  300 
   Cofilin phosphorylation. LIM kinase (10) has also been shown to be a ROK substrate, and 301
phosphorylation at T508 within the activation loop activates this kinase (32). Activated LIM kinase in 302 
turn phosphorylates the actin capping and severing protein, cofilin, at S3 (7,44). In the unphosphorylated 303 
state, cofilin binds to and severs actin filaments and this effect is alleviated upon phosphorylation at S3 304 
(1). We examined the time course of cofilin phosphorylation in rabbit urethral smooth muscle in 305 
response to KCl and phenylephrine by western blotting with a phosphospecific antibody that recognizes 306 
cofilin only when phosphorylated at S3. As shown in Fig. 8, cofilin is phosphorylated at S3 in the 307 
unstimulated tissue and its phosphorylation level does not change significantly during the time course of 308 
contraction in response to either KCl or phenylephrine.  309 
   Actin polymerization. We also measured actin polymerization during the time course of the contractile 310
response to KCl and phenylephrine. Urethral tissue strips were homogenized in F-actin stabilization 311 
solution at the times indicated in Fig. 4A and B, and F- and G-actin were separated by high-speed 312 
centrifugation. Fig. 9A demonstrates that SM-22, a 22 kDa smooth muscle-specific protein (30), was 313 
recovered exclusively in the high-speed supernatant and, therefore, provides a suitable protein for 314 
normalization of loading levels. The high-speed supernatant, containing all the G-actin, was then 315 
analysed by western blotting with anti-actin and loading levels were normalized to SM-22 (Fig. 9B). If 316 
KCl and phenylephrine induce actin polymerization that is required for force production in the urethra, 317 
we would anticipate that the G-actin content would decline rapidly in response to both stimuli and would 318 
increase again during relaxation upon washout. This was not found to be the case (Fig. 9B).   319 
   Comparison of LC20 phosphorylation in rabbit urethra, bladder and aorta. The very high level of 320
basal phosphorylation of LC20 in the rabbit urethra at resting tension (0.65 mol Pi/mol LC20) was 321 
unexpected, as was the absence of an increase in response to membrane depolarization or α1-322 
adrenoceptor activation (Table 1). Therefore, we investigated whether the same was true for another 323 
phasic urogenital smooth muscle (bladder) and a tonic vascular smooth muscle (aorta). As for the 324 
urethra, the basal level of LC20 phosphorylation in bladder smooth muscle was high and did not 325 
significantly change in response to KCl or phenylephrine (Table 3). On the other hand, the basal level of 326 
LC20 phosphorylation in the aorta was lower and did increase in response to both KCl and phenylephrine 327 
(Table 3). 328 
   LC20 phosphorylation in rat urethra and bladder. The role of LC20 phosphorylation in contraction of 329
urethra and bladder smooth muscles was also investigated in rat tissues. In contrast to the situation with 330 
rabbit tissues, LC20 phosphorylation in rat urethra and bladder was relatively low at resting tension and 331 
increased in response to both KCl and phenylephrine (Table 4).  332 
   Comparison of methods for quenching of tissues prior to LC20 phosphorylation analysis. During the 333
course of this work, we discovered that the method for quenching of rabbit urethral smooth muscle strips 334 
for biochemical analysis was crucial. This is often achieved by immersing the tissue in 335 
TCA/acetone/DTT on dry ice or clamping the tissue between liquid nitrogen-cooled tongs, immersing it 336 
in TCA/acetone/DTT on dry ice and slowly warming the tissue to room temperature in 337 
TCA/acetone/DTT. However, we found that these procedures resulted in very low levels of LC20 338 
phosphorylation (Table 5). On the other hand, immersing the tissue in TCA/acetone/DTT on wet ice 339 
gave much higher and reproducible phosphorylation stoichiometry (Table 1). We also quenched the 340 
tissues by immersion in liquid nitrogen, followed by transfer directly to boiling SDS-gel sample buffer. 341 
After incubation at 95 oC for 10 min, samples were rotated overnight at 4 oC prior to Phos-tag SDS-342 
PAGE. As shown in Supplementary Figure 3 and Supplementary Table 1, very low levels of LC20 343 
phosphorylation stoichiometry were measured under these conditions. In addition, rabbit urethral 344 
smooth muscle strips were clamped between liquid nitrogen-cooled tongs at rest and at the plateau of 345 
KCl- or phenylephrine-induced contractions and then treated in one of the following ways: (i) tissues 346 
were immersed in TCA/acetone/DTT on wet ice; (ii) tissues were immersed in TCA/acetone/DTT on 347 
dry ice; or (iii) tissues were immersed in liquid N2. Tissues from (i) and (ii) were then lyophilized 348 
overnight after washing with acetone/DTT. All three sets of tissues were then immersed in boiling SDS-349 
gel sample buffer, maintained at 95 oC for 10 min, and rotated at 4 oC overnight prior to Phos-tag SDS-350 
PAGE to quantify LC20 phosphorylation levels. The results confirmed a high level of resting LC20 351 
phosphorylation when tissues freeze-clamped with liquid N2-cooled tongs were immersed in 352 
TCA/acetone/DTT on wet ice (Supplementary Table 2). On the other hand, much lower levels of LC20 353 
phosphorylation were measured when tissues freeze-clamped with liquid N2-cooled tongs were 354 
immersed in TCA/acetone/DTT on dry ice. Even lower levels of LC20 phosphorylation were measured 355 
when tissues freeze-clamped with liquid N2-cooled tongs were immersed in liquid N2.    356 
The effects of removal of extracellular Ca2+ and pre-incubation with wortmannin on rabbit urethral 357 
smooth muscle contraction and LC20 phosphorylation. Finally, to identify the kinase responsible for the 358 
high level of LC20 phosphorylation in the rabbit urethra under resting conditions, the effect on LC20 359 
phosphorylation of removal of extracellular Ca2+ and pre-incubation with wortmannin (10 μM), which at 360 
this concentration is a MLCK inhibitor, was investigated. Incubation of urethral tissue strips in Ca2+-free 361 
Krebs solution containing 10 mM EGTA for 30 min resulted in a marked decrease in LC20 362 
phosphorylation and resting tension (Table 6). Treatment with KCl (80 mM) or phenylephrine (10 μM) 363 
after pre-incubation of tissue strips in Ca2+-free Krebs solution containing 10 mM EGTA for 30 min 364 
failed to elicit a contractile response or an increase in LC20 phosphorylation (Table 6). Preincubation of 365 
tissue strips with wortmannin (10 μM) in Krebs solution also reduced the resting level of LC20 366 
phosphorylation and reduced resting tension by over 50% (Table 6). Addition of KCl (80 mM) after 367 
incubation with wortmannin for 30 min failed to elicit a contractile response or an increase in LC20 368 
phosphorylation (Table 6).         369 
 370
DISCUSSION 371 
The most interesting findings from this study were that the urethra and bladder of the rabbit had a 372 
high level of LC20 phosphorylation at resting tension, and that membrane depolarization and α1-373 
adrenoceptor stimulation did not increase the level of LC20 phosphorylation (Figs. 3 and 4 and Table 1), 374 
in spite of inducing robust contractile responses (Figs. 1 and 2). Vascular smooth muscle of the rabbit 375 
(aorta), on the other hand, behaved as expected, i.e., LC20 phosphorylation increased in response to 376 
membrane depolarization and α1-adrenoceptor stimulation (Table 3). Rat urethra and bladder, however, 377 
had a low level of LC20 phosphorylation at rest, which increased in response to membrane depolarization 378 
and α1-adrenoceptor stimulation, indicating species specificity (Table 4). It will be important in the 379 
future to determine whether human urethral and bladder smooth muscles behave like the rabbit or rat 380 
counterparts. 381 
    Another key finding from this study was that the contractile responses to electric field stimulation, 382
KCl and phenylephrine were all potently inhibited by Y27632 and H1152, two structurally unrelated 383 
inhibitors of ROK (Figs. 1 and 2). It is important to note that, although highly selective, these 384 
compounds can inhibit other kinases such as PRK2, AMPK and, to a lesser degree, PDK11 (9). PRK2 385 
and PDK11 have not been implicated in the regulation of smooth muscle contraction and AMPK has 386 
been shown to phosphorylate and inactivate smooth muscle MLCK (20). Given our observation that 387 
Y27632 and H1152 had no effect on LC20 phosphorylation (Fig. 3D and Table 1), it is unlikely that the 388 
inhibitory effects of Y27632 and H1152 on contraction involve inhibition of AMPK.  389 
 The RhoA/ROK pathway has previously been implicated in agonist-induced contraction of the rat 390
urethra (37) and spontaneous tone in female porcine urethral smooth muscle (28). Extensive studies of 391 
various smooth muscles have implicated the RhoA/ROK pathway in Ca2+ sensitization, i.e., an increase 392 
in force at a given [Ca2+]i. This pathway results in inhibition of MLCP via phosphorylation of the 393 
myosin targeting subunit of MLCP (MYPT1) and/or CPI-17 by ROK, which results in increased LC20 394 
phosphorylation and contraction (33). Since ROK inhibition did not alter LC20 phosphorylation in rabbit 395 
urethral smooth muscle (Fig. 3 and Table 1), we concluded that MLCP inhibition is not involved in the 396 
contractile response to KCl or phenylephrine. This conclusion was supported by the fact that MYPT1 397 
phosphorylation at the two inhibitory ROK sites did not increase in response to either stimulus (Figs. 5 398 
and 6 and Table 2), although phosphorylation could be greatly enhanced by treatment with the 399 
phosphatase inhibitor, microcystin (Fig. 7), indicating that resting phosphorylation at T697 and T855 400 
was sub-stoichiometric. We did not pursue the phosphorylation of CPI-17 since tissue levels of this 401 
protein were very low in comparison to vascular smooth muscles (Supplementary Fig. 2), consistent 402 
with reports in the literature that CPI-17 is most highly expressed in tonic vascular smooth muscles and 403 
least in phasic visceral smooth muscles (43), and PKC, which is known to phosphorylate CPI-17 at T38, 404 
is not involved in rabbit urethral smooth muscle contraction in response to electric field stimulation, 405 
membrane depolarization or α1-adrenoceptor stimulation (Supplementary Fig. 1). Furthermore, the fact 406 
that ROK inhibition had no effect on LC20 phosphorylation supports the conclusion that CPI-17 does not 407 
have a role in the contractile responses observed.  408 
    Another ROK substrate that may play a role in regulation of contractility is LIM kinase, which 409
contains two LIM domains, zinc finger domains originally identified in the proteins Lin11, Isl-1 and 410 
Mec-3 (8). This kinase is activated by ROK-catalysed phosphorylation within the activation loop. The 411 
activated LIM kinase phosphorylates the actin capping and severing protein cofilin at S3, whereupon it 412 
loses the ability to bind to actin and sever actin filaments (10). Actin polymerization has been implicated 413 
in smooth muscle contraction, and dephosphorylation of cofilin at S3 favors actin polymerization by 414 
increasing the availability of barbed ends of actin filaments (17). This would predict that 415 
dephosphorylation of cofilin, and not ROK/LIM kinase-mediated phosphorylation at S3 would occur in 416 
response to contractile stimulation, and a decrease in phosphocofilin has been demonstrated in canine 417 
tracheal smooth muscle treated with acetylcholine or KCl, which is associated with actin polymerization 418 
and contraction (45). Nevertheless, we investigated cofilin phosphorylation in rabbit urethral smooth 419 
muscle. While cofilin exhibited a basal level of S3 phosphorylation under resting tension, there was no 420 
change in cofilin phosphorylation in response to membrane depolarization or α1-adrenoceptor 421 
stimulation (Fig. 8). Furthermore, there was no change in G-actin content in response to KCl or 422 
phenylephrine (Fig. 9). We concluded, therefore, that the ROK/LIM kinase/cofilin pathway is not 423 
responsible for membrane depolarization- or α1-adrenoceptor stimulation-induced contraction of rabbit 424 
urethral smooth muscle.  425 
    The phosphatase inhibitor calyculin-A induced diphosphorylation of LC20 (Fig. 3A and B) and 426
contraction of intact urethral smooth muscle (data not shown). We have shown previously that LC20 427 
diphosphorylation occurs at S19 and T18 in vascular smooth muscle, and is catalysed by integrin-linked 428 
kinase, not MLCK (14,40). We did not observe any LC20 diphosphorylation in urethral smooth muscle 429 
under resting conditions or in response to KCl or phenylephrine (e.g., Fig. 3) and conclude that ILK is 430 
not responsible for the high level of LC20 phosphorylation observed at rest or in the presence of these 431 
contractile stimuli. ROK has been shown to phosphorylate LC20 directly in vitro, although this does not 432 
appear to occur in situ (34). The fact that ROK inhibition by H1152 had no effect on LC20 433 
phosphorylation under resting conditions or in the presence of KCl or phenylephrine (Fig. 3D and Table 434 
1) indicates that ROK is not responsible for the observed phosphorylation of LC20. At resting tension, 435 
LC20 phosphorylation was almost abolished by removal of extracellular Ca2+ or by addition of 436 
wortmannin (MLCK inhibitor) in the presence of 2.5 mM extracellular Ca2+ (Table 6). Furthermore, KCl 437 
and phenylephrine failed to elicit a contractile response in the absence of extracellular Ca2+ or in the 438 
presence of wortmannin at 2.5 mM extracellular Ca2+ (Table 6). These results indicate that MLCK is the 439 
kinase responsible for LC20 phosphorylation in the rabbit urethra at rest and in the presence of KCl and 440 
phenylephrine.     441 
    The method used to quench the urethral tissue strips for biochemical analysis proved crucial. If tissues 442
were immersed in TCA/acetone/DTT on dry ice, or clamped between liquid nitrogen-cooled tongs prior 443 
to immersion in TCA/acetone/DTT on dry ice and gradual warming to room temperature, the levels of 444 
LC20 phosphorylation were consistently very low at rest and did not change in response to KCl or 445 
phenylephrine (Table 5). On the other hand, if tissues were immersed in TCA/acetone/DTT on wet ice, 446 
the levels of LC20 phosphorylation were consistently much higher at rest, and again did not change in 447 
response to KCl or phenylephrine (Table 1). These results suggest that the use of TCA/acetone/DTT on 448 
dry ice does not rapidly quench cellular biochemical reactions so that LC20 is dephosphorylated by 449 
MLCP that remains active under these conditions.  If the tissue was freeze-clamped between liquid 450 
nitrogen-cooled tongs, and subsequently immersed in TCA/acetone/DTT on wet ice or dry ice, or in 451 
liquid nitrogen, differences in LC20 phosphorylation levels were again observed (Table 5 and 452 
Supplementary Table 2). In the case of immersion in wet ice-cooled TCA/acetone/DTT, resting LC20 453 
stoichiometry was 0.36 mol Pi/mol LC20, which did not change in response to contractile stimuli 454 
(Supplementary Table 2). On the other hand, very low levels of LC20 phosphorylation were measured in 455 
the cases of tissues that had been freeze-clamped between liquid nitrogen-cooled tongs and then 456 
immersed in dry-ice-cooled TCA/acetone/DTT or liquid nitrogen. Furthermore, for tissues that were 457 
immersed directly in liquid nitrogen and then transferred to boiling SDS-gel sample buffer, the 458 
measured stoichiometry of LC20 phosphorylation was again very low (Supplementary Fig. 3 and 459 
Supplementary Table 1), consistent with a very high tissue phosphatase activity. We interpret these 460 
results as follows: freeze-clamping the tissue between liquid nitrogen-cooled tongs, or plunging the 461 
tissue in liquid nitrogen or dry ice-cooled TCA/acetone/DTT dramatically reduces the phosphatase 462 
activity, but as the tissue warms up in SDS-gel sample buffer or TCA/acetone/DTT the phosphatase 463 
becomes active again and dephosphorylates LC20 before a sufficiently high temperature is reached to 464 
denature the phosphatase. It appears unlikely that immersion of tissue in wet ice-cooled 465 
TCA/acetone/DTT would lead to activation of MLCK since the kinase requires Ca2+, Mg2+ and ATP for 466 
activity and none are present in the quench solution. Our observation that immersion of unstimulated rat 467 
tissues in wet ice-cooled TCA/acetone/DTT gave the expected low basal levels of LC20 phosphorylation 468 
also argues against activation of MLCK under these quenching conditions. It is also clear from the 469 
results presented that any manipulation involving rapid freezing of the rabbit urethra results in low 470 
levels of LC20 phosphorylation under both resting and stimulated conditions. In particular, it is apparent 471 
from Supplementary Table 2 that freeze-clamping the tissue with liquid nitrogen-cooled tongs followed 472 
by immersion in wet ice-cooled TCA/acetone/DTT yields lower and more variable LC20 473 
phosphorylation stoichiometry (0.36 ± 0.07 mol Pi/mol LC20) than direct immersion in wet ice-cooled 474 
TCA/acetone/DTT (0.65 ± 0.02 mol Pi/mol LC20), consistent with phosphatase activity 475 
dephosphorylating LC20 during sample work-up. Furthermore, we compared the basal level of LC20 476 
phosphorylation at 0.5 g resting tension with that when no tension was applied to the tissue, and found 477 
no statistically significant difference by Student’s t-test (p > 0.05): 0.66 ± 0.03 (n = 18) and 0.71 ± 0.11 478 
(n = 10) mol Pi/mol LC20, respectively. Also, if tissue at zero tension was quenched with dry ice-cooled 479 
TCA/acetone/DTT, low levels of LC20 phosphorylation were measured (0.11 ± 0.05 mol Pi/mol LC20; n 480 
= 6). Caution must, therefore, be exercised when choosing a method of tissue quenching for 481 
quantification of LC20 phosphorylation in rabbit tissues.      482 
        Future studies will be directed towards identification of ROK substrates in rabbit urethra with a 483
view to defining the mechanism of activation of contraction without an increase in LC20 484 
phosphorylation. 485 
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Table 1  LC20 phosphorylation in rabbit urethral smooth muscle treated with KCl or 609 
phenylephrine, and the effect of ROK inhibition 610 
 611 
Conditions mol Pi/mol LC20 
  
Control 0.65 ± 0.02 (21) 
KCl 
Phenylephrine 
0.63 ± 0.03 (22)  
0.62 ± 0.03 (19) 
H1152 0.55 ± 0.05 (7) 
KCl + H1152 
Phenylephrine + H1152 
0.56 ± 0.03 (6) 
0.57 ± 0.06 (7) 
 
 612
 613
Rabbit urethral smooth muscle strips were treated with KCl, phenylephrine or vehicle with or without 614 
pre-incubation with the ROK inhibitor H1152 (see legend to Fig. 2). Tissues were immersed in 615 
TCA/acetone/DTT on wet ice at the peak of contraction, and LC20 phosphorylation was analysed by 616 
Phos-tag SDS-PAGE. Values indicate the mean ± SEM (n values given in parentheses). No significant 617 
differences from control were observed by one-way ANOVA with Dunnett’s post-hoc test (p > 0.05). 618 
619 
Table 2   MYPT1 phosphorylation in rabbit urethral smooth muscle treated with KCl or 620 
phenylephrine  621 
 622
Conditions pT697 pT855 
 
KCl 
 
0.86 ± 0.09 (7) 
 
0.88 ± 0.118 (7) 
Phenylephrine 1.25 ± 0.21 (9) 1.38 ± 0.14 (9) 
 623
Rabbit urethral smooth muscle strips were treated with KCl, phenylephrine, or vehicle (see legend to 624 
Fig. 2). Tissues were immersed in TCA/acetone/DTT on wet ice at the peak of contraction, and MYPT1 625 
phosphorylation at T697 and T855 was analysed by western blotting with phosphospecific antibodies. 626 
Values indicate signal intensities relative to control after normalization of loading levels ± SEM with n 627 
values in parentheses. No significant differences from control (set at a value of 1) were observed by 628 
Student’s t test (p > 0.05). 629 
630 
Table 3 LC20 phosphorylation in rabbit urethral, bladder and aortic smooth muscles treated with 631 
KCL or phenylephrine 632 
 633 
Conditions Urethra 
(mol Pi/molLC20) 
Bladder 
(mol Pi/mol LC20) 
 
Aorta 
(mol Pi/molLC20) 
Control 0.67 ± 0.07 0.63 ± 0.06 0.45 ± 0.05 
KCl 0.70 ± 0.03 0.67 ± 0.01 0.59 ± 0.05* 
Phenylephrine 0.70 ± 0.02 0.59 ± 0.06 0.65 ± 0.04* 
 634
 635
Rabbit urethral, bladder and aortic smooth muscle strips were treated with KCl, phenylephrine, or 636 
vehicle (see legend to Fig. 2). Tissues were immersed in TCA/acetone/DTT on wet ice at the peak of 637 
contraction, and LC20 phosphorylation was analysed by Phos-tag SDS-PAGE. Values indicate the mean 638 
± SEM (n = 6 for urethra, 3 for bladder and 5 for aorta). Statistically significant differences from control 639 
are indicated with asterisks (*p < 0.05) as determined by one-way ANOVA with Dunnett’s post-hoc 640 
test. 641 
642 
Table 4   LC20 phosphorylation in rat urethral and bladder smooth muscles treated with KCl or 643 
phenylephrine 644 
  645
Conditions Urethra Bladder 
 (mol Pi/mol LC20) (mol Pi/mol LC20) 
 
Control 
KCl 
Phenylephrine 
 
0.13 ± 0.05 
0.37±  0.07* 
0.41 ± 0.04** 
0.21 ± 0.06 
0.43 ± 0.06* 
0.45 ± 0.06* 
 646
Rat urethral and bladder smooth muscle strips were treated with KCl, phenylephrine, or vehicle (see 647 
legend to Fig. 2). Tissues were immersed in TCA/acetone/DTT on wet ice at the peak of contraction, 648 
and LC20 phosphorylation was analysed by Phos-tag SDS-PAGE. Values indicate the mean ± SEM (n = 649 
4). Statistically significant differences from control are indicated with asterisks (*p < 0.5; **p < 0.01), 650 
as determined by one-way ANOVA with Dunnett’s post-hoc test. 651 
652 
Table 5   LC20 phosphorylation in rabbit urethral smooth muscle treated with KCl or 653 
phenylephrine, and quenched in TCA/acetone/DTT on dry ice or clamped between liquid 654 
nitrogen-cooled tongs 655 
 656 
Conditions  Treatment (i) 
(mol Pi/mol LC20) 
Treatment (ii) 
(mol Pi/mol LC20) 
Control 0.05 ± 0.01 (14) 0.04 ± 0.01 (3) 
KCl 0.12 ± 0.03 (10) 0.07 ± 0.02 (3) 
Phenylephrine 0.07 ± 0.02 (11) 0.04 ± 0.01 (3) 
 
 657
Rabbit urethral smooth muscle strips were treated with KCl, phenylephrine or vehicle (see legend to Fig. 658 
2). (i) Tissues at the peak of contraction were immersed in TCA/acetone/DTT on dry ice, and then 659 
washed (3 x 1 ml) in acetone/DTT, the liquid poured off and the tissue lyophilized; or (ii) tissues at the 660 
peak of contraction were quick frozen by clamping between liquid nitrogen cooled tongs, immersed in 661 
TCA/acetone/DTT on dry ice, slowly (1 h) warmed to room temperature, washed (3 x 1 ml) in 662 
acetone/DTT, the liquid poured off and the tissue was frozen on dry ice and lyophilized.  LC20 663 
phosphorylation was analysed by Phos-tag SDS-PAGE. Values indicate the mean ± SEM (n values in 664 
parentheses). No statistically significant differences from control were detected by one-way ANOVA 665 
with Dunnett’s post-hoc test (p > 0.05). 666 
667 
Table 6   The effects of removal of extracellular Ca2+ and pre-incubation with wortmannin on 668 
LC20 phosphorylation and contraction in rabbit urethral smooth muscle    669 
 670
Conditions mol Pi/mol LC20 Contractile response 
 
Control 
 
0.70 ± 0.02 
 
None 
0 Ca2+ 0.13 ± 0.08** Relaxation (43.8 ± 5.8%) 
KCl 0.66 ± 0.04 Contraction 
0 Ca2+ + KCl 0.16 ± 0.03** None 
Phenylephrine 0.65 ± 0.05 Contraction 
0 Ca2+ + phenylephrine 0.06 ± 0.04** None 
Wortmannin 0.16 ± 0.07** Relaxation (52.8 ± 9.0%) 
Wortmannin + KCl 0.06 ± 0.02** None 
 
 671
Rabbit urethral smooth muscle strips were treated with KCl, phenylephrine or vehicle (see legend to Fig. 672 
2) and the contractile responses were recorded. Tissues were immersed in TCA/acetone/DTT on wet ice, 673 
and LC20 phosphorylation was analysed by Phos-tag SDS-PAGE. Values indicate phosphorylation 674 
stoichiometry ± SEM (2 tissue strips from each of 2 animals were analysed in each case). Statistically 675 
significant differences from control, as indicated by one-way ANOVA with Dunnett’s post-hoc test, are 676 
indicated with asterisks (**p < 0.01). 677 
678 
FIGURE LEGENDS  679 
Fig. 1. Effects of ROK inhibition on urethral smooth muscle contraction. Rabbit urethral smooth muscle 680 
strips were dissected, mounted on a force transducer at resting tension and perfused with Krebs solution 681 
at 37 oC for at least 1 h. Two control contraction-relaxation cycles were recorded prior to incubation of 682 
the tissue with either H1152 (1 µM) or Y27632 (10 μM) for 15 min. Two contraction-relaxation cycles 683 
were recorded in the continued presence of inhibitor. The inhibitor was then washed out and two control 684 
contraction-relaxation cycles recorded again.  A, representative traces depicting the effects of H1152 on 685 
contractions elicited by EFS (upper panel), KCl (middle panel) and phenylephrine (lower panel). B, 686 
cumulative data showing the effects of ROK inhibitors on contractions elicited by:  electric field 687 
stimulation (EFS) at 4 Hz in the presence of H1152 (n = 6) or Y27632 (n = 8 with Y27632 and n = 6 688 
following washout),  KCl (80 mM) stimulation in the presence of H1152 (n = 5 with H1152 and n = 7 689 
following washout) or Y27632 (n = 4), or phenylephrine (PHE; 10 μM) stimulation in the presence of 690 
H1152 (n = 6) or Y27632 (n = 9 with Y27632 and n = 8 following washout). Values indicate maximal 691 
tension as a percentage of the average tension of the initial control responses. Recovery (grey bars) 692 
indicates the average tension response following washout of the inhibitor (not significantly different 693 
from control).  Statistically significant differences from control (absence of H1152), detected by one-694 
way ANOVA with Dunnett’s post-hoc test, are indicated by asterisks (**p < 0.01, n = 5). C, Effect of 695 
H1152 on sustained phenylephrine-induced contraction of urethral smooth muscle. Rabbit urethral 696 
smooth muscle strips equilibrated in Krebs solution at 37 oC were contracted with phenylephrine (10 697 
μM). Following washout and relaxation, a sustained contractile response was elicited with 698 
phenylephrine. H1152 (1 μM) was added in the continued presence of phenylephrine, following which 699 
both phenylephrine and H1152 were washed out and a final control sustained contraction elicited with 700 
phenylephrine.  701 
Fig. 2. Effect of H1152 on phenylephrine-induced contraction of non-perfused rabbit urethral smooth 702 
muscle strips at 21 oC. Rabbit urethral smooth muscle strips were dissected, mounted on a force 703 
transducer at resting tension and equilibrated with Krebs solution at 21 oC for at least 1 h. A, Two 704 
control phenylephrine (10 μM)-induced contraction-relaxation cycles were recorded prior to incubation 705 
of the tissue with H1152 (1 μM) for 15 min. Two contraction-relaxation cycles were recorded in the 706 
continued presence of inhibitor, which was then washed out and two control contraction-relaxation 707 
cycles recorded again. B, Following two control phenylephrine-induced contraction-relaxation cycles, 708 
phenylephrine was added again. The phenylephrine solution was changed 7 times and force was 709 
maintained. Following washout, another contraction was elicited by phenylephrine and increasing 710 
concentrations of H1152 (0.1, 0.25, 0.5, 1, 2.5, 5 and 10 μM) were applied in the continued presence of 711 
phenylephrine, followed by washout of phenylephrine and H1152. Although not clearly apparent in this 712 
figure, due to compression of the time scale, steady-state force was achieved before each addition of 713 
H1152, as seen on the expanded time scale of the recorder. C, Cumulative data showing the effects of 714 
increasing H1152 concentration on phenylephrine-induced contraction. In these experiments, longer 715 
time intervals were used between successive additions of H1152 than in panel B to ensure that steady-716 
state force had been achieved.   717 
Fig. 3. LC20 phosphorylation in rabbit urethral smooth muscle treated with phenylephrine or KCl, and 718 
the effect of ROK inhibition. Rabbit urethral smooth muscle strips were dissected, mounted on a force 719 
transducer at resting tension and equilibrated with Krebs solution at 21 oC for at least 1 h prior to 720 
treatment with phenylephrine (10 μM), KCl (80 mM), calyculin-A (5 μM) or vehicle (control). Tissues 721 
were quenched in TCA/DTT in acetone on wet ice once steady-state force was developed, washed with 722 
DTT in acetone and lyophilized overnight before extraction of tissue proteins with SDS-gel sample 723 
buffer. Phosphorylated and unphosphorylated forms of the 20 kDa myosin regulatory light chains (LC20) 724 
were separated by SDS-PAGE (in duplicate) with polyacrylamide-bound Mn2+-phosphate-binding tag 725 
(Phos-tag SDS-PAGE) and detected by western blotting with anti-LC20 (A) or phosphospecific anti-726 
LC20, which recognizes only LC20 phosphorylated at S19 (B). “LC20” denotes unphosphorylated LC20, 727 
“P1-LC20” denotes LC20 phosphorylated at S19 and “P2-LC20” denotes LC20 phosphorylated at S19 and 728 
T18. The position of the 28 kDa marker is indicated at the right. C, Triplicate samples of muscle strips 729 
treated with KCl (80 mM) or phenylephrine (10 μM) were subjected to Phos-tag SDS-PAGE in the 730 
presence of MnCl2 (upper panel) or EDTA (lower panel). The position of the 26 kDa marker is indicated 731 
at the right.  D, Rabbit urethral smooth muscle strips were pre-incubated with the ROK inhibitor H1152 732 
(1 μM) prior to addition of phenylephrine (10 μM), KCl (80 mM) or vehicle. LC20 phosphorylation was 733 
analysed by Phos-tag SDS-PAGE. The position of the 28 kDa marker is indicated at the right.  734 
Fig. 4. Time courses of LC20 phosphorylation in rabbit urethral smooth muscle treated with KCl or 735 
phenylephrine. Typical KCl (80 mM)- (A) and phenylephrine (10 μM)-induced (B) contractile 736 
responses. Numbers indicate the times during contractions at which tissues were quenched for Phos-tag 737 
SDS-PAGE analysis of LC20 phosphorylation (C). D, Cumulative data (values indicate the mean ± SEM, 738 
n = 3 for KCl and n = 2 for phenylephrine).    739 
Fig. 5. MYPT1 phosphorylation in rabbit urethral smooth muscle treated with KCl or phenylephrine. 740 
Rabbit urethral smooth muscle strips were treated with phenylephrine (10 μM), KCl (80 mM) or vehicle 741 
(control) and the phosphorylation of MYPT1 at the peak of the contractile response was analysed in 742 
triplicate by western blotting with phosphospecific antibodies that recognize MYPT1 phosphorylated at 743 
T697 or T855. Loading levels were normalized to the actin-binding protein calponin. 744 
Fig. 6. Time courses of MYPT1 phosphorylation in rabbit urethral smooth muscle treated with KCl or 745 
phenylephrine. Rabbit urethral smooth muscle strips were treated with 80 mM KCl (A) or 10 μM 746 
phenylephrine (B) and the phosphorylation of MYPT1 was analysed in triplicate at selected times during 747 
the contractile response by western blotting with phosphospecific antibodies that recognize MYPT1 748 
phosphorylated at T697 or T855. Loading levels were normalized to actin. Numbers beneath gel lanes 749 
indicate the times during contractions at which tissues were quenched for western analysis of MYPT1 750 
phosphorylation (see Fig. 4A and B). C, Cumulative data (values indicate the mean ± SEM, n = 4 for 751 
KCl and n = 3 for phenylephrine).    752 
Fig. 7. Phosphatase inhibition with microcystin markedly increases MYPT1 phosphorylation at T697 753 
and T855. Rabbit urethral smooth muscle strips (intact or Triton-skinned) were treated with KCl (80 754 
mM, intact strips), microcystin (10 μM, Triton-skinned strips) or vehicle (control, intact strips) and the 755 
phosphorylation of MYPT1 (130 kDa) analysed in triplicate by western blotting with phosphospecific 756 
antibodies. Loading levels were normalized to calponin (32 kDa). “M” denotes the molecular weight 757 
marker lane.       758 
Fig. 8. Cofilin phosphorylation in rabbit urethral smooth muscle treated with KCl or phenylephrine. 759 
Rabbit urethral smooth muscle strips were treated with 80 mM KCl (A) or 10 μM phenylephrine (C) and 760 
the phosphorylation of cofilin was analysed at selected times during the contractile response by western 761 
blotting with phosphospecific antibodies that recognize cofilin phosphorylated at S3. Loading levels 762 
were normalized to LC20 and calponin. Numbers beneath gel lanes indicate the times during contractions 763 
at which tissues were quenched for analysis of cofilin phosphorylation (see Fig. 4A and B). B and D, 764 
Cumulative data for KCl- and phenylephrine-induced contractions, respectively (values indicate the 765 
mean ± SEM, n = 4 (B), n = 3 (D)).    766 
Fig. 9. Analysis of actin polymerization during KCl- and phenylephrine-induced contraction of rabbit 767 
urethra. Rabbit urethral smooth muscle strips were treated with KCl (80 mM) or phenylephrine (10 μM). 768 
Tissues were homogenized, centrifuged at low speed to remove cell debris and then at high speed to 769 
separate F- and G-actin. The high-speed supernatants and pellets were analysed by western blotting with 770 
anti-actin and anti-SM-22, and representative results are shown in A: lanes 1, 3, 6 and 8: KCl-treated 771 
tissues (15, 7.5, 7.5 and 15 μl, respectively); lanes 2, 4, 5 and 7: phenylephrine-treated tissues (15, 7.5, 772 
7.5 and 15 μl, respectively). B, Tissues were homogenized at selected times during the contractions and 773 
centrifuged at high speed to remove F-actin. The high-speed supernatants were analysed by western 774 
blotting with anti-actin and anti-SM-22. Time courses in response to KCl or phenylephrine treatment are 775 
shown. Numbers beneath gel lanes in (B) indicate the times during contractions at which tissues were 776 
homogenized for western analysis of actin and SM-22 (see Fig. 4A and B). 777 
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